<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37612439</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Plasma miR-195-5p predicts the severity of Covid-19 in hospitalized patients.</ArticleTitle><Pagination><StartPage>13806</StartPage><MedlinePgn>13806</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">13806</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-40754-w</ELocationID><Abstract><AbstractText>Predicting the clinical course of Covid-19 is a challenging task, given the multi-systemic character of the disease and the paucity of minimally invasive biomarkers of disease severity. Here, we evaluated the early (first two days post-admission) level of circulating hsa-miR-195-5p (miR-195, a known responder to viral infections and SARS-CoV-2 interactor) in Covid-19 patients and assessed its potential as a biomarker of disease severity. We show that plasma miR-195 correlates with several clinical and paraclinical parameters, and is an excellent discriminator between the severe and mild forms of the disease. Our Gene Ontology analysis of miR-195 targets differentially expressed in Covid-19 indicates a strong impact on cardiac mitochondria homeostasis, suggesting a possible role in long Covid and chronic fatigue syndrome (CFS) syndromes.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moatar</LastName><ForeName>Alexandra Ioana</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, Discipline of Biochemistry, University of Medicine and Pharmacy "Victor Babes", E Murgu Square no.2, 300041, Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School, University of Medicine and Pharmacy "Victor Babes", E Murgu Square no.2, 300041, Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chis</LastName><ForeName>Aimee Rodica</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, Discipline of Biochemistry, University of Medicine and Pharmacy "Victor Babes", E Murgu Square no.2, 300041, Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Complex Network Science, University of Medicine and Pharmacy "Victor Babes", E Murgu Square no.2, 300041, Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romanescu</LastName><ForeName>Mirabela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, Discipline of Biochemistry, University of Medicine and Pharmacy "Victor Babes", E Murgu Square no.2, 300041, Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School, University of Medicine and Pharmacy "Victor Babes", E Murgu Square no.2, 300041, Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciordas</LastName><ForeName>Paula-Diana</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, Discipline of Biochemistry, University of Medicine and Pharmacy "Victor Babes", E Murgu Square no.2, 300041, Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School, University of Medicine and Pharmacy "Victor Babes", E Murgu Square no.2, 300041, Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nitusca</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, Discipline of Biochemistry, University of Medicine and Pharmacy "Victor Babes", E Murgu Square no.2, 300041, Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School, University of Medicine and Pharmacy "Victor Babes", E Murgu Square no.2, 300041, Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marian</LastName><ForeName>Catalin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, Discipline of Biochemistry, University of Medicine and Pharmacy "Victor Babes", E Murgu Square no.2, 300041, Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Complex Network Science, University of Medicine and Pharmacy "Victor Babes", E Murgu Square no.2, 300041, Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oancea</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Discipline of Pulmonology, University of Medicine and Pharmacy "Victor Babes", E. Murgu Square no.2, 300041, Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Innovation in Precision Medicine of Respiratory Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, E. Murgu Square 2, 300041, Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sirbu</LastName><ForeName>Ioan-Ovidiu</ForeName><Initials>IO</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, Discipline of Biochemistry, University of Medicine and Pharmacy "Victor Babes", E Murgu Square no.2, 300041, Timisoara, Romania. ovidiu.sirbu@umft.ro.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Complex Network Science, University of Medicine and Pharmacy "Victor Babes", E Murgu Square no.2, 300041, Timisoara, Romania. ovidiu.sirbu@umft.ro.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Timisoara Institute of Complex Systems, 18 Vasile Lucaciu Str, 300044, Timisoara, Romania. ovidiu.sirbu@umft.ro.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C552722">MIRN195 microRNA, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010361" MajorTopicYN="N">Patients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>24</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37612439</ArticleId><ArticleId IdType="pmc">PMC10447562</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-40754-w</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-40754-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bartel DP. Metazoan microRNAs. Cell. 2018;173(1):20&#x2013;51. doi: 10.1016/j.cell.2018.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.006</ArticleId><ArticleId IdType="pmc">PMC6091663</ArticleId><ArticleId IdType="pubmed">29570994</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhlmann S, et al. Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer. Mol. Syst. Biol. 2012;8:570. doi: 10.1038/msb.2011.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/msb.2011.100</ArticleId><ArticleId IdType="pmc">PMC3293631</ArticleId><ArticleId IdType="pubmed">22333974</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman RC, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92&#x2013;105. doi: 10.1101/gr.082701.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.082701.108</ArticleId><ArticleId IdType="pmc">PMC2612969</ArticleId><ArticleId IdType="pubmed">18955434</ArticleId></ArticleIdList></Reference><Reference><Citation>Girardi E, L&#xf3;pez P, Pfeffer S. On the importance of host MicroRNAs during viral infection. Front. Genet. 2018;9:439. doi: 10.3389/fgene.2018.00439.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00439</ArticleId><ArticleId IdType="pmc">PMC6176045</ArticleId><ArticleId IdType="pubmed">30333857</ArticleId></ArticleIdList></Reference><Reference><Citation>Siniscalchi C, et al. Human MicroRNAs interacting with SARS-CoV-2 RNA sequences: Computational analysis and experimental target validation. Front. Genet. 2021;12:678994. doi: 10.3389/fgene.2021.678994.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.678994</ArticleId><ArticleId IdType="pmc">PMC8215607</ArticleId><ArticleId IdType="pubmed">34163530</ArticleId></ArticleIdList></Reference><Reference><Citation>Akula SM, Bolin P, Cook PP. Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene. RNA Biol. 2022;19(1):1&#x2013;11. doi: 10.1080/15476286.2021.2010959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2021.2010959</ArticleId><ArticleId IdType="pmc">PMC8786335</ArticleId><ArticleId IdType="pubmed">34904915</ArticleId></ArticleIdList></Reference><Reference><Citation>Trobaugh DW, Klimstra WB. MicroRNA regulation of RNA virus replication and pathogenesis. Trends Mol. Med. 2017;23(1):80&#x2013;93. doi: 10.1016/j.molmed.2016.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2016.11.003</ArticleId><ArticleId IdType="pmc">PMC5836316</ArticleId><ArticleId IdType="pubmed">27989642</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon-Icaza SA, Zeng M, Rosas-Taraco AG. microRNAs in viral acute respiratory infections: Immune regulation, biomarkers, therapy, and vaccines. ExRNA. 2019;1(1):1. doi: 10.1186/s41544-018-0004-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41544-018-0004-7</ArticleId><ArticleId IdType="pmc">PMC7149109</ArticleId><ArticleId IdType="pubmed">34171007</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou L, et al. The SARS-CoV-2 protein NSP2 impairs the silencing capacity of the human 4EHP-GIGYF2 complex. iScience. 2022;25(7):104646. doi: 10.1016/j.isci.2022.104646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104646</ArticleId><ArticleId IdType="pmc">PMC9213009</ArticleId><ArticleId IdType="pubmed">35756894</ArticleId></ArticleIdList></Reference><Reference><Citation>Trobaugh DW, et al. RNA viruses can hijack vertebrate microRNAs to suppress innate immunity. Nature. 2014;506(7487):245&#x2013;248. doi: 10.1038/nature12869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12869</ArticleId><ArticleId IdType="pmc">PMC4349380</ArticleId><ArticleId IdType="pubmed">24352241</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, et al. SARS-COV-2 as potential microRNA sponge in COVID-19 patients. BMC Med. Genom. 2022;15(2):94. doi: 10.1186/s12920-022-01243-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-022-01243-7</ArticleId><ArticleId IdType="pmc">PMC9034446</ArticleId><ArticleId IdType="pubmed">35461273</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoszewski R, et al. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs. Am. J. Physiol. Lung Cell. Mol. Physiol. 2020;319(3):L444&#x2013;l455. doi: 10.1152/ajplung.00252.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00252.2020</ArticleId><ArticleId IdType="pmc">PMC7473886</ArticleId><ArticleId IdType="pubmed">32755307</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao Y, et al. Epstein-Barr virus circRNAome as host miRNA sponge regulates virus infection, cell cycle, and oncogenesis. Bioengineered. 2019;10(1):593&#x2013;603. doi: 10.1080/21655979.2019.1679698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21655979.2019.1679698</ArticleId><ArticleId IdType="pmc">PMC6844377</ArticleId><ArticleId IdType="pubmed">31668120</ArticleId></ArticleIdList></Reference><Reference><Citation>Cazalla D, Steitz JA. Down-regulation of a host microRNA by a viral noncoding RNA. Cold Spring Harb. Symp. Quant. Biol. 2010;75:321&#x2013;324. doi: 10.1101/sqb.2010.75.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/sqb.2010.75.009</ArticleId><ArticleId IdType="pmc">PMC5647998</ArticleId><ArticleId IdType="pubmed">21139068</ArticleId></ArticleIdList></Reference><Reference><Citation>Luna JM, et al. Hepatitis C virus RNA functionally sequesters miR-122. Cell. 2015;160(6):1099&#x2013;1110. doi: 10.1016/j.cell.2015.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.02.025</ArticleId><ArticleId IdType="pmc">PMC4386883</ArticleId><ArticleId IdType="pubmed">25768906</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell PS, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA. 2008;105(30):10513&#x2013;10518. doi: 10.1073/pnas.0804549105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804549105</ArticleId><ArticleId IdType="pmc">PMC2492472</ArticleId><ArticleId IdType="pubmed">18663219</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawlica P, et al. SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes. Proc. Natl. Acad. Sci. USA. 2021;118(52):e2116668118. doi: 10.1073/pnas.2116668118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2116668118</ArticleId><ArticleId IdType="pmc">PMC8719879</ArticleId><ArticleId IdType="pubmed">34903581</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M, et al. A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection. EMBO Rep. 2022;23(2):e54341. doi: 10.15252/embr.202154341.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202154341</ArticleId><ArticleId IdType="pmc">PMC8811647</ArticleId><ArticleId IdType="pubmed">34914162</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales L, et al. SARS-CoV-encoded small RNAs contribute to infection-associated lung pathology. Cell Host Microbe. 2017;21(3):344&#x2013;355. doi: 10.1016/j.chom.2017.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2017.01.015</ArticleId><ArticleId IdType="pmc">PMC5662013</ArticleId><ArticleId IdType="pubmed">28216251</ArticleId></ArticleIdList></Reference><Reference><Citation>Tribolet L, et al. MicroRNA biomarkers for infectious diseases: From basic research to biosensing. Front. Microbiol. 2020;11:1197. doi: 10.3389/fmicb.2020.01197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01197</ArticleId><ArticleId IdType="pmc">PMC7286131</ArticleId><ArticleId IdType="pubmed">32582115</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Z, et al. A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease. Cell Discov. 2021;7(1):48. doi: 10.1038/s41421-021-00289-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00289-8</ArticleId><ArticleId IdType="pmc">PMC8257610</ArticleId><ArticleId IdType="pubmed">34226530</ArticleId></ArticleIdList></Reference><Reference><Citation>Grehl C, et al. Detection of SARS-CoV-2 derived small RNAs and changes in circulating small RNAs associated with COVID-19. Viruses. 2021;13(8):1593. doi: 10.3390/v13081593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081593</ArticleId><ArticleId IdType="pmc">PMC8402885</ArticleId><ArticleId IdType="pubmed">34452458</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng F, et al. Viral MicroRNAs encoded by nucleocapsid gene of SARS-CoV-2 are detected during infection, and targeting metabolic pathways in host cells. Cells. 2021;10(7):1762. doi: 10.3390/cells10071762.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071762</ArticleId><ArticleId IdType="pmc">PMC8307234</ArticleId><ArticleId IdType="pubmed">34359932</ArticleId></ArticleIdList></Reference><Reference><Citation>Farr RJ, et al. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection. PLoS Pathog. 2021;17(7):e1009759. doi: 10.1371/journal.ppat.1009759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009759</ArticleId><ArticleId IdType="pmc">PMC8318295</ArticleId><ArticleId IdType="pubmed">34320031</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald JT, et al. Role of miR-2392 in driving SARS-CoV-2 infection. Cell Rep. 2021;37(3):109839. doi: 10.1016/j.celrep.2021.109839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109839</ArticleId><ArticleId IdType="pmc">PMC8481092</ArticleId><ArticleId IdType="pubmed">34624208</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, et al. Differential microRNA expression in the peripheral blood from human patients with COVID-19. J. Clin. Lab. Anal. 2020;34(10):e23590. doi: 10.1002/jcla.23590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23590</ArticleId><ArticleId IdType="pmc">PMC7536972</ArticleId><ArticleId IdType="pubmed">32960473</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A, et al. Circulating cardiovascular microRNAs in critically ill COVID-19 patients. Eur. J. Heart Fail. 2021;23(3):468&#x2013;475. doi: 10.1002/ejhf.2096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2096</ArticleId><ArticleId IdType="pmc">PMC8014268</ArticleId><ArticleId IdType="pubmed">33421274</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H, et al. The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19. Clin. Transl. Med. 2020;10(6):e200. doi: 10.1002/ctm2.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.200</ArticleId><ArticleId IdType="pmc">PMC7548099</ArticleId><ArticleId IdType="pubmed">33135345</ArticleId></ArticleIdList></Reference><Reference><Citation>Saulle I, et al. MiRNA profiling in plasma and placenta of SARS-CoV-2-infected pregnant women. Cells. 2021;10(7):1788. doi: 10.3390/cells10071788.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071788</ArticleId><ArticleId IdType="pmc">PMC8305278</ArticleId><ArticleId IdType="pubmed">34359957</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients. Signal Transduct. Target Ther. 2021;6(1):300. doi: 10.1038/s41392-021-00716-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00716-y</ArticleId><ArticleId IdType="pmc">PMC8355568</ArticleId><ArticleId IdType="pubmed">34381015</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, et al. Potential therapeutic effect of micrornas in extracellular vesicles from mesenchymal stem cells against SARS-CoV-2. Cells. 2021;10(9):2393. doi: 10.3390/cells10092393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10092393</ArticleId><ArticleId IdType="pmc">PMC8465096</ArticleId><ArticleId IdType="pubmed">34572043</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbatinelli J, et al. Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients. Mech. Ageing Dev. 2021;193:111413. doi: 10.1016/j.mad.2020.111413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2020.111413</ArticleId><ArticleId IdType="pmc">PMC7722494</ArticleId><ArticleId IdType="pubmed">33307107</ArticleId></ArticleIdList></Reference><Reference><Citation>Centa A, et al. Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients. Am. J. Physiol. Lung Cell Mol. Physiol. 2020;320(3):L405&#x2013;L412. doi: 10.1152/ajplung.00457.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00457.2020</ArticleId><ArticleId IdType="pmc">PMC7938642</ArticleId><ArticleId IdType="pubmed">33651636</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayyad-Kazan M, et al. Circulating miRNAs: Potential diagnostic role for coronavirus disease 2019 (COVID-19) Infect. Genet. Evol. 2021;94:105020. doi: 10.1016/j.meegid.2021.105020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.105020</ArticleId><ArticleId IdType="pmc">PMC8325559</ArticleId><ArticleId IdType="pubmed">34343725</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagheri-Hosseinabadi Z, et al. The relationship between serum levels of interleukin-2 and IL-8 with circulating microRNA-10b in patients with COVID-19. Iran. J. Immunol. 2021;18(1):65&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">33787515</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CX, et al. Whole-transcriptome RNA sequencing reveals significant differentially expressed mRNAs, miRNAs, and lncRNAs and related regulating biological pathways in the peripheral blood of COVID-19 patients. Mediators Inflamm. 2021;2021:6635925. doi: 10.1155/2021/6635925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6635925</ArticleId><ArticleId IdType="pmc">PMC8018221</ArticleId><ArticleId IdType="pubmed">33833618</ArticleId></ArticleIdList></Reference><Reference><Citation>Keikha R, Hashemi-Shahri SM, Jebali A. The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization. Eur. J. Med. Res. 2021;26(1):75. doi: 10.1186/s40001-021-00544-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-021-00544-4</ArticleId><ArticleId IdType="pmc">PMC8276226</ArticleId><ArticleId IdType="pubmed">34256840</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimenta R, et al. MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19. Mol. Biol. Res. Commun. 2021;10(3):141&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340313</ArticleId><ArticleId IdType="pubmed">34476267</ArticleId></ArticleIdList></Reference><Reference><Citation>Donyavi T, et al. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a&#x2013;3p, 155&#x2013;5p, and let-7b-3p in PBMC. Int. Immunopharmacol. 2021;97:107641. doi: 10.1016/j.intimp.2021.107641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107641</ArticleId><ArticleId IdType="pmc">PMC8023203</ArticleId><ArticleId IdType="pubmed">33895478</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassif-Lerner R, et al. miR-155: A potential biomarker for predicting mortality in COVID-19 patients. J. Pers. Med. 2022;12(2):324. doi: 10.3390/jpm12020324.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12020324</ArticleId><ArticleId IdType="pmc">PMC8877479</ArticleId><ArticleId IdType="pubmed">35207812</ArticleId></ArticleIdList></Reference><Reference><Citation>Linsley PS, et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol. Cell. Biol. 2007;27(6):2240&#x2013;2252. doi: 10.1128/MCB.02005-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.02005-06</ArticleId><ArticleId IdType="pmc">PMC1820501</ArticleId><ArticleId IdType="pubmed">17242205</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandi N, et al. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res. 2009;69(13):5553&#x2013;5559. doi: 10.1158/0008-5472.CAN-08-4277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-08-4277</ArticleId><ArticleId IdType="pubmed">19549910</ArticleId></ArticleIdList></Reference><Reference><Citation>Devadas K, et al. Identification of host micro RNAs that differentiate HIV-1 and HIV-2 infection using genome expression profiling techniques. Viruses. 2016;8(5):121. doi: 10.3390/v8050121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8050121</ArticleId><ArticleId IdType="pmc">PMC4885076</ArticleId><ArticleId IdType="pubmed">27144577</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas S, et al. Development and validation of plasma miRNA biomarker signature panel for the detection of early HIV-1 infection. EBioMedicine. 2019;43:307&#x2013;316. doi: 10.1016/j.ebiom.2019.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.04.023</ArticleId><ArticleId IdType="pmc">PMC6557912</ArticleId><ArticleId IdType="pubmed">31005516</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, et al. MicroRNA-195 suppresses enterovirus A71-induced pyroptosis in human neuroblastoma cells through targeting NLRX1. Virus Res. 2021;292:198245. doi: 10.1016/j.virusres.2020.198245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198245</ArticleId><ArticleId IdType="pubmed">33253716</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow JT, Salmena L. Prediction and analysis of SARS-CoV-2-targeting MicroRNA in human lung epithelium. Genes (Basel) 2020;11(9):1002. doi: 10.3390/genes11091002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes11091002</ArticleId><ArticleId IdType="pmc">PMC7565861</ArticleId><ArticleId IdType="pubmed">32858958</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181(5):1036&#x2013;1045.e9. doi: 10.1016/j.cell.2020.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kgatle MM, et al. COVID-19 is a multi-organ aggressor: Epigenetic and clinical marks. Front. Immunol. 2021;12:752380. doi: 10.3389/fimmu.2021.752380.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.752380</ArticleId><ArticleId IdType="pmc">PMC8531724</ArticleId><ArticleId IdType="pubmed">34691068</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Schulze PC. MicroRNAs in heart failure: Non-coding regulators of metabolic function. Biochim. Biophys. Acta. 2016;1862(12):2276&#x2013;2287. doi: 10.1016/j.bbadis.2016.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.08.009</ArticleId><ArticleId IdType="pmc">PMC5376502</ArticleId><ArticleId IdType="pubmed">27544699</ArticleId></ArticleIdList></Reference><Reference><Citation>Long G, et al. Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS ONE. 2012;7(12):e50926. doi: 10.1371/journal.pone.0050926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0050926</ArticleId><ArticleId IdType="pmc">PMC3517576</ArticleId><ArticleId IdType="pubmed">23236408</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng D, et al. Inhibition of MicroRNA 195 prevents apoptosis and multiple-organ injury in mouse models of sepsis. J. Infect. Dis. 2016;213(10):1661&#x2013;1670. doi: 10.1093/infdis/jiv760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv760</ArticleId><ArticleId IdType="pmc">PMC4837905</ArticleId><ArticleId IdType="pubmed">26704614</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HY, et al. miR-195 has a potential to treat ischemic and hemorrhagic stroke through neurovascular protection and neurogenesis. Mol. Ther. Methods Clin. Dev. 2019;13:121&#x2013;132. doi: 10.1016/j.omtm.2018.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2018.11.011</ArticleId><ArticleId IdType="pmc">PMC6365409</ArticleId><ArticleId IdType="pubmed">30775405</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, et al. miR-195-5p alleviates acute kidney injury through repression of inflammation and oxidative stress by targeting vascular endothelial growth factor A. Aging (Albany NY) 2020;12(11):10235&#x2013;10245. doi: 10.18632/aging.103160.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103160</ArticleId><ArticleId IdType="pmc">PMC7346085</ArticleId><ArticleId IdType="pubmed">32492657</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin J-Z, Wang S-J, Xia C. microRNAs regulate nitric oxide release from endothelial cells by targeting NOS3. J. Thromb. Thrombolysis. 2018;46(3):275&#x2013;282. doi: 10.1007/s11239-018-1684-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-018-1684-4</ArticleId><ArticleId IdType="pubmed">29948755</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparello J, Finotti A, Gambari R. Tackling the COVID-19 "cytokine storm" with microRNA mimics directly targeting the 3'UTR of pro-inflammatory mRNAs. Med. Hypotheses. 2021;146:110415. doi: 10.1016/j.mehy.2020.110415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110415</ArticleId><ArticleId IdType="pmc">PMC7685948</ArticleId><ArticleId IdType="pubmed">33422363</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, et al. System-wide transcriptome damage and tissue identity loss in COVID-19 patients. Cell. Rep. Med. 2022;3(2):100522. doi: 10.1016/j.xcrm.2022.100522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100522</ArticleId><ArticleId IdType="pmc">PMC8784611</ArticleId><ArticleId IdType="pubmed">35233546</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N. Engl. J. Med. 2020;383(25):2451&#x2013;2460. doi: 10.1056/NEJMcp2009575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp2009575</ArticleId><ArticleId IdType="pubmed">32412710</ArticleId></ArticleIdList></Reference><Reference><Citation>de Bruin S, et al. Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine. 2021;67:103378. doi: 10.1016/j.ebiom.2021.103378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103378</ArticleId><ArticleId IdType="pmc">PMC8118723</ArticleId><ArticleId IdType="pubmed">34000622</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AP, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int. Immunopharmacol. 2020;84:106504. doi: 10.1016/j.intimp.2020.106504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.106504</ArticleId><ArticleId IdType="pmc">PMC7152924</ArticleId><ArticleId IdType="pubmed">32304994</ArticleId></ArticleIdList></Reference><Reference><Citation>Yekelchyk M, et al. Flower lose, a cell fitness marker, predicts COVID-19 prognosis. EMBO Mol. Med. 2021;13(11):e13714. doi: 10.15252/emmm.202013714.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202013714</ArticleId><ArticleId IdType="pmc">PMC8573598</ArticleId><ArticleId IdType="pubmed">34661368</ArticleId></ArticleIdList></Reference><Reference><Citation>de Gonzalo-Calvo D, et al. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients. Transl. Res. 2021;236:147&#x2013;159. doi: 10.1016/j.trsl.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8149473</ArticleId><ArticleId IdType="pubmed">34048985</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutmann C, et al. Association of cardiometabolic microRNAs with COVID-19 severity and mortality. Cardiovasc. Res. 2022;118(2):461&#x2013;474. doi: 10.1093/cvr/cvab338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab338</ArticleId><ArticleId IdType="pmc">PMC8689968</ArticleId><ArticleId IdType="pubmed">34755842</ArticleId></ArticleIdList></Reference><Reference><Citation>Parray A, et al. SnoRNAs and miRNAs networks underlying COVID-19 disease severity. Vaccines (Basel) 2021;9(10):1056. doi: 10.3390/vaccines9101056.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9101056</ArticleId><ArticleId IdType="pmc">PMC8538251</ArticleId><ArticleId IdType="pubmed">34696164</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliani A, et al. Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality. Mech. Ageing Dev. 2022;202:111636. doi: 10.1016/j.mad.2022.111636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2022.111636</ArticleId><ArticleId IdType="pmc">PMC8809668</ArticleId><ArticleId IdType="pubmed">35122770</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Pato A, et al. Plasma miRNA profile at COVID-19 onset predicts severity status and mortality. Emerg. Microbes Infect. 2022;11(1):676&#x2013;688. doi: 10.1080/22221751.2022.2038021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2038021</ArticleId><ArticleId IdType="pmc">PMC8890551</ArticleId><ArticleId IdType="pubmed">35130828</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson D, et al. Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies. EBioMedicine. 2022;78:103982. doi: 10.1016/j.ebiom.2022.103982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103982</ArticleId><ArticleId IdType="pmc">PMC8989492</ArticleId><ArticleId IdType="pubmed">35405523</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA. 2020;324(8):782&#x2013;793. doi: 10.1001/jama.2020.12839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan CA, et al. High frequency of SARS-CoV-2 RNAemia and association with severe disease. Clin. Infect. Dis. 2021;72(9):e291&#x2013;e295. doi: 10.1093/cid/ciaa1054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1054</ArticleId><ArticleId IdType="pmc">PMC7543277</ArticleId><ArticleId IdType="pubmed">32965474</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang K, et al. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019. J. Med. Virol. 2021;93(5):3165&#x2013;3175. doi: 10.1002/jmv.26876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26876</ArticleId><ArticleId IdType="pmc">PMC8014647</ArticleId><ArticleId IdType="pubmed">33590923</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram-Mohan N, et al. SARS-CoV-2 RNAemia predicts clinical deterioration and extrapulmonary complications from COVID-19. Clin. Infect. Dis. 2022;74(2):218&#x2013;226. doi: 10.1093/cid/ciab394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab394</ArticleId><ArticleId IdType="pmc">PMC8135992</ArticleId><ArticleId IdType="pubmed">33949665</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, et al. Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin. Infect. Dis. 2020;71(8):1937&#x2013;1942. doi: 10.1093/cid/ciaa449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa449</ArticleId><ArticleId IdType="pmc">PMC7184354</ArticleId><ArticleId IdType="pubmed">32301997</ArticleId></ArticleIdList></Reference><Reference><Citation>Olea B, et al. Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: Relationship with biomarkers of disease severity. J. Infect. 2021;83(3):381&#x2013;412. doi: 10.1016/j.jinf.2021.05.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.05.036</ArticleId><ArticleId IdType="pmc">PMC8168298</ArticleId><ArticleId IdType="pubmed">34087349</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutmann C, et al. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat. Commun. 2021;12(1):3406. doi: 10.1038/s41467-021-23494-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23494-1</ArticleId><ArticleId IdType="pmc">PMC8184784</ArticleId><ArticleId IdType="pubmed">34099652</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa R, et al. Combined kinetic analysis of SARS-CoV-2 RNAemia, N-antigenemia and virus-specific antibodies in critically ill adult COVID-19 patients. Sci. Rep. 2022;12(1):8273. doi: 10.1038/s41598-022-12461-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-12461-5</ArticleId><ArticleId IdType="pmc">PMC9114819</ArticleId><ArticleId IdType="pubmed">35585163</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D, et al. Relationship between serum severe acute respiratory syndrome coronavirus 2 nucleic acid and organ damage in coronavirus 2019 patients: A cohort study. Clin. Infect. Dis. 2021;73(1):68&#x2013;75. doi: 10.1093/cid/ciaa1085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1085</ArticleId><ArticleId IdType="pmc">PMC7454386</ArticleId><ArticleId IdType="pubmed">32720678</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersisyan S, et al. Potential role of cellular miRNAs in coronavirus-host interplay. PeerJ. 2020;8:e9994. doi: 10.7717/peerj.9994.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.9994</ArticleId><ArticleId IdType="pmc">PMC7497610</ArticleId><ArticleId IdType="pubmed">32983652</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WR, et al. Expression analyses of MicroRNAs in hamster lung tissues infected by SARS-CoV-2. Mol. Cells. 2020;43(11):953&#x2013;963. doi: 10.14348/molcells.2020.0177.</Citation><ArticleIdList><ArticleId IdType="doi">10.14348/molcells.2020.0177</ArticleId><ArticleId IdType="pmc">PMC7700842</ArticleId><ArticleId IdType="pubmed">33199671</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepe G, et al. Evaluation of potential miRNA sponge effects of SARS genomes in human. Noncoding RNA Res. 2022;7(1):48&#x2013;53. doi: 10.1016/j.ncrna.2022.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2022.01.003</ArticleId><ArticleId IdType="pmc">PMC8769905</ArticleId><ArticleId IdType="pubmed">35075440</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, et al. microRNA arm-imbalance in part from complementary targets mediated decay promotes gastric cancer progression. Nat. Commun. 2019;10(1):4397. doi: 10.1038/s41467-019-12292-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12292-5</ArticleId><ArticleId IdType="pmc">PMC6764945</ArticleId><ArticleId IdType="pubmed">31562301</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, et al. The miRNA: A small but powerful RNA for COVID-19. Brief Bioinform. 2021;22(2):1137&#x2013;1149. doi: 10.1093/bib/bbab062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbab062</ArticleId><ArticleId IdType="pmc">PMC7989616</ArticleId><ArticleId IdType="pubmed">33675361</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah ASV, et al. Clinical burden, risk factor impact and outcomes following myocardial infarction and stroke: A 25-year individual patient level linkage study. Lancet Reg. Health Eur. 2021;7:100141. doi: 10.1016/j.lanepe.2021.100141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100141</ArticleId><ArticleId IdType="pmc">PMC8351196</ArticleId><ArticleId IdType="pubmed">34405203</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebert M, et al. PIWI proteins contribute to apoptosis during the UPR in human airway epithelial cells. Sci. Rep. 2018;8(1):16431. doi: 10.1038/s41598-018-34861-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34861-2</ArticleId><ArticleId IdType="pmc">PMC6219583</ArticleId><ArticleId IdType="pubmed">30401887</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung TS, Liu DX. Coronavirus infection, ER stress, apoptosis and innate immunity. Front. Microbiol. 2014;5:296. doi: 10.3389/fmicb.2014.00296.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2014.00296</ArticleId><ArticleId IdType="pmc">PMC4060729</ArticleId><ArticleId IdType="pubmed">24987391</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnier N, et al. Altered microRNA expression in severe COVID-19: Potential prognostic and pathophysiological role. Clin. Transl. Med. 2022;12(6):e899. doi: 10.1002/ctm2.899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.899</ArticleId><ArticleId IdType="pmc">PMC9191908</ArticleId><ArticleId IdType="pubmed">35696619</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Chen T, Zhou Y. Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes. Hereditas. 2021;158(1):4. doi: 10.1186/s41065-020-00168-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41065-020-00168-4</ArticleId><ArticleId IdType="pmc">PMC7781406</ArticleId><ArticleId IdType="pubmed">33397514</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh KK, et al. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am. J. Physiol. Cell. Physiol. 2020;319(2):C258&#x2013;c267. doi: 10.1152/ajpcell.00224.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00224.2020</ArticleId><ArticleId IdType="pmc">PMC7381712</ArticleId><ArticleId IdType="pubmed">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Elesela S, Lukacs NW. Role of mitochondria in viral infections. Life (Basel) 2021;11(3):232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7998235</ArticleId><ArticleId IdType="pubmed">33799853</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang C, et al. SARS-CoV-2 causes mitochondrial dysfunction and mitophagy impairment. Front. Microbiol. 2021;12:780768. doi: 10.3389/fmicb.2021.780768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.780768</ArticleId><ArticleId IdType="pmc">PMC8770829</ArticleId><ArticleId IdType="pubmed">35069483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran K, et al. SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics. iScience. 2022;25(1):103722. doi: 10.1016/j.isci.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8720045</ArticleId><ArticleId IdType="pubmed">35005527</ArticleId></ArticleIdList></Reference><Reference><Citation>Purohit PK, et al. MiR-195 regulates mitochondrial function by targeting mitofusin-2 in breast cancer cells. RNA Biol. 2019;16(7):918&#x2013;929. doi: 10.1080/15476286.2019.1600999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2019.1600999</ArticleId><ArticleId IdType="pmc">PMC6546347</ArticleId><ArticleId IdType="pubmed">30932749</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, et al. MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1. Sci. Rep. 2015;5(1):17454. doi: 10.1038/srep17454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep17454</ArticleId><ArticleId IdType="pmc">PMC4668367</ArticleId><ArticleId IdType="pubmed">26632252</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, et al. MiR-195 dependent roles of mitofusin2 in the mitochondrial dysfunction of hippocampal neurons in SAMP8 mice. Brain Res. 2016;1652:135&#x2013;143. doi: 10.1016/j.brainres.2016.09.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.09.047</ArticleId><ArticleId IdType="pubmed">27693395</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi H, et al. MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. J. Biol. Chem. 2010;285(7):4920&#x2013;4930. doi: 10.1074/jbc.M109.082610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.082610</ArticleId><ArticleId IdType="pmc">PMC2836096</ArticleId><ArticleId IdType="pubmed">20007690</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh J, et al. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion. 2020;54:1&#x2013;7. doi: 10.1016/j.mito.2020.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7837003</ArticleId><ArticleId IdType="pubmed">32574708</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A. Novel coronavirus-induced NLRP3 inflammasome activation: A potential drug target in the treatment of COVID-19. Front. Immunol. 2020;11:1021. doi: 10.3389/fimmu.2020.01021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01021</ArticleId><ArticleId IdType="pmc">PMC7248552</ArticleId><ArticleId IdType="pubmed">32574259</ArticleId></ArticleIdList></Reference><Reference><Citation>Burtscher J, Millet GP, Burtscher M. Low cardiorespiratory and mitochondrial fitness as risk factors in viral infections: Implications for COVID-19. Br. J. Sports Med. 2021;55(8):413&#x2013;415. doi: 10.1136/bjsports-2020-103572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2020-103572</ArticleId><ArticleId IdType="pubmed">33234508</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H, et al. MiR-195-5p represses inflammation, apoptosis, oxidative stress, and endoplasmic reticulum stress in sepsis-induced myocardial injury by targeting activating transcription factor 6. Cell. Biol. Int. 2022;46(2):243&#x2013;254. doi: 10.1002/cbin.11726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.11726</ArticleId><ArticleId IdType="pubmed">34816499</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C, et al. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS ONE. 2017;12(10):e0186802. doi: 10.1371/journal.pone.0186802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186802</ArticleId><ArticleId IdType="pmc">PMC5655451</ArticleId><ArticleId IdType="pubmed">29065167</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong CW, et al. Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients. Metabolomics. 2015;11(6):1626&#x2013;1639. doi: 10.1007/s11306-015-0816-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-015-0816-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E, et al. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction. J. Transl. Med. 2020;18(1):365. doi: 10.1186/s12967-020-02533-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02533-3</ArticleId><ArticleId IdType="pmc">PMC7512220</ArticleId><ArticleId IdType="pubmed">32972442</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer E, et al. Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome. Am. J. Respir. Crit. Care Med. 2022;205(1):126&#x2013;129. doi: 10.1164/rccm.202108-1903LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202108-1903LE</ArticleId><ArticleId IdType="pmc">PMC8865580</ArticleId><ArticleId IdType="pubmed">34665688</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, et al. Persistent exertional intolerance after COVID-19: Insights from invasive cardiopulmonary exercise testing. Chest. 2022;161(1):54&#x2013;63. doi: 10.1016/j.chest.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Bermejo JA, et al. SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19. Sci. Transl. Med. 2021;13(590):eabf7872. doi: 10.1126/scitranslmed.abf7872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf7872</ArticleId><ArticleId IdType="pmc">PMC8128284</ArticleId><ArticleId IdType="pubmed">33723017</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45. doi: 10.1093/nar/29.9.e45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/29.9.e45</ArticleId><ArticleId IdType="pmc">PMC55695</ArticleId><ArticleId IdType="pubmed">11328886</ArticleId></ArticleIdList></Reference><Reference><Citation>Sticht C, et al. miRWalk: An online resource for prediction of microRNA binding sites. PLoS ONE. 2018;13(10):e0206239. doi: 10.1371/journal.pone.0206239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0206239</ArticleId><ArticleId IdType="pmc">PMC6193719</ArticleId><ArticleId IdType="pubmed">30335862</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, et al. STRING v11: Protein&#x2013;protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607&#x2013;d613. doi: 10.1093/nar/gky1131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1131</ArticleId><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>